Status:

RECRUITING

Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears

Lead Sponsor:

Arthrex, Inc.

Conditions:

Full-thickness Rotator Cuff Tear

Eligibility:

All Genders

30-75 years

Brief Summary

The purpose of this study is to compare postoperative healing of large and massive rotator cuff tears with preoperative MRI confirmed fatty infiltration stage II and higher repaired with or without de...

Detailed Description

The primary objective is to evaluate postoperative healing of rotator cuff repair with and without DAA. Primary: The primary outcome measure is healing evaluation in MRI . MRI Post-Operative Assessme...

Eligibility Criteria

Inclusion

  • The subject is between the ages of 30 and 75 years.
  • Subject is planning to undergo arthroscopic surgery for full-thickness rotator cuff tear (RCT)
  • Two complete RCTs or tear size equal to or greater than 3 cm in either the anterior-posterior or medial-lateral dimension
  • Primary rotator cuff repair
  • Stage II fatty infiltration or higher of the supraspinatus or infraspinatus muscle based on preoperative MRI6. Subject has a dual x-ray absorptiometry (DXA) or anterior posterior x-ray view of the target shoulder

Exclusion

  • The Subject is unable or unwilling to sign the patient informed consent, approved by the Institutional Review Board.
  • The subject objects to the use of allograft
  • Stage I or lower fatty infiltration of the supraspinatus AND infraspinatus muscle
  • Complete full-thickness subscapularis tears of greater than the superior one third of the tendon (Lafosse grade 3 and above)
  • Less than 2 mm joint space of the glenohumeral joint on either an anteroposterior or axillary radiograph
  • Recurrent shoulder instability
  • Corticosteroid injection in the operative shoulder within one month of surgery
  • Revision rotator cuff repair
  • Subject preoperative MRI obtained more than 12 months prior to surgery
  • Pregnant or planning to become pregnant during the study period
  • Workman's compensation case
  • Subject has conditions or circumstances that would interfere with study requirements.
  • Intraoperative exclusion criteria:
  • Partial rotator cuff repairs
  • Lafosse grade 3 or higher subscapularis tears

Key Trial Info

Start Date :

September 25 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 15 2026

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT05981833

Start Date

September 25 2023

End Date

September 15 2026

Last Update

February 24 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

University of Arizona, Banner Health

Scottsdale, Arizona, United States, 85006

2

Orthopaedic & Nuerosurgery Specialists

Greenwich, Connecticut, United States, 06831

3

Southern Oregon Orthopedics Research Foundation

Medford, Oregon, United States, 97504

4

Tennessee Orthopedic Foundation for Research Education and Research

Nashville, Tennessee, United States, 37204